{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T01:25:58Z","timestamp":1782005158755,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,24]]},"DOI":"10.7759\/cureus.30641","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T19:57:28Z","timestamp":1666641448000},"source":"Crossref","is-referenced-by-count":1,"title":["Haloperidol Versus Atypical Antipsychotics for Treating Delirium in Intensive Care Unit Patients: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Akhil","family":"Sadhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hameeda","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijeoma","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahvish","family":"Anam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrinkhala","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab","family":"Amjad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrahman","family":"Abaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Advait M","family":"Vasavada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safeera","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60688-1","article-title":"Delirium in elderly people","volume":"383","author":"Inouye SK","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet. 2014, 383:911-22. 10.1016\/S0140-6736(13)60688-1","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29540","article-title":"Delirium in older patients with COVID-19 presenting to the emergency department","volume":"3","author":"Kennedy M","year":"2020","unstructured":"Kennedy M, Helfand BK, Gou RY, et al.. Delirium in older patients with COVID-19 presenting to the emergency department. JAMA Netw Open. 2020, 3:e2029540. 10.1001\/jamanetworkopen.2020.29540","journal-title":"JAMA Netw Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5114\/ait.2020.95164","article-title":"COVID-19: what do we need to know about ICU delirium during the SARS-CoV-2 pandemic?","volume":"52","author":"Kotfis K","year":"2020","unstructured":"Kotfis K, Williams Roberson S, Wilson J, et al.. COVID-19: what do we need to know about ICU delirium during the SARS-CoV-2 pandemic?. Anaesthesiol Intensive Ther. 2020, 52:132-8. 10.5114\/ait.2020.95164","journal-title":"Anaesthesiol Intensive Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-63599-0.00025-9","article-title":"Delirium in critically ill patients","volume":"141","author":"Slooter AJ","year":"2017","unstructured":"Slooter AJ, Van De Leur RR, Zaal IJ. Delirium in critically ill patients. Handb Clin Neurol. 2017, 141:449-66. 10.1016\/B978-0-444-63599-0.00025-9","journal-title":"Handb Clin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009783","article-title":"Interventions for preventing intensive care unit delirium in adults","volume":"23","author":"Herling SF","year":"2018","unstructured":"Herling SF, Greve IE, Vasilevskis EE, Mortensen CB, M\u00f8ller AM, Svenningsen H, Thomsen T. Interventions for preventing intensive care unit delirium in adults. Cochrane Database Syst Rev. 2018, 23:009783. 10.1002\/14651858.CD009783","journal-title":"Cochrane Database Syst Rev"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005594.pub3","article-title":"Antipsychotics for treatment of delirium in hospitalised non-ICU patients","volume":"6","author":"Burry L","year":"2018","unstructured":"Burry L, Mehta S, Perreault MM, et al.. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2018, 6:CD005594. 10.1002\/14651858.CD005594.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.11468","article-title":"Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial","volume":"318","author":"Hui D","year":"2017","unstructured":"Hui D, Frisbee-Hume S, Wilson A, et al.. Effect of lorazepam with haloperidol vs haloperidol alone on agitated delirium in patients with advanced cancer receiving palliative care: a randomized clinical trial. JAMA. 2017, 318:1047-56. 10.1001\/jama.2017.11468","journal-title":"JAMA"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808217","article-title":"Haloperidol and ziprasidone for treatment of delirium in critical illness","volume":"379","author":"Girard TD","year":"2018","unstructured":"Girard TD, Exline MC, Carson SS, et al.. Haloperidol and ziprasidone for treatment of delirium in critical illness. N Engl J Med. 2018, 379:2506-16. 10.1056\/NEJMoa1808217","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004976","article-title":"Association between incident delirium treatment with haloperidol and mortality in critically ill adults","volume":"49","author":"Duprey MS","year":"2021","unstructured":"Duprey MS, Devlin JW, van der Hoeven JG, et al.. Association between incident delirium treatment with haloperidol and mortality in critically ill adults. Crit Care Med. 2021, 49:1303-11. 10.1097\/CCM.0000000000004976","journal-title":"Crit Care Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, et al.. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021, 372:n160. 10.1136\/bmj.n160","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2019.09.017","article-title":"Efficacy and safety of haloperidol for delirium prevention in adult patients: an updated meta-analysis with trial sequential analysis of randomized controlled trials","volume":"61","author":"Chen Z","year":"2020","unstructured":"Chen Z, Chen R, Zheng D, et al.. Efficacy and safety of haloperidol for delirium prevention in adult patients: an updated meta-analysis with trial sequential analysis of randomized controlled trials. J Clin Anesth. 2020, 61:109623. 10.1016\/j.jclinane.2019.09.017","journal-title":"J Clin Anesth"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2020.01.010","article-title":"Can haloperidol prophylaxis reduce the incidence of delirium in critically ill patients in intensive care units? A systematic review and meta-analysis","volume":"49","author":"Lin P","year":"2020","unstructured":"Lin P, Zhang J, Shi F, Liang ZA. Can haloperidol prophylaxis reduce the incidence of delirium in critically ill patients in intensive care units? A systematic review and meta-analysis. Heart Lung. 2020, 49:265-72. 10.1016\/j.hrtlng.2020.01.010","journal-title":"Heart Lung"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.psym.2018.05.011","article-title":"Efficacy and tolerability of atypical antipsychotics in the treatment of delirium: a systematic review of the literature","volume":"60","author":"Rivi\u00e8re J","year":"2019","unstructured":"Rivi\u00e8re J, van der Mast RC, Vandenberghe J, Van Den Eede F. Efficacy and tolerability of atypical antipsychotics in the treatment of delirium: a systematic review of the literature. Psychosomatics. 2019, 60:18-26. 10.1016\/j.psym.2018.05.011","journal-title":"Psychosomatics"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.07.005","article-title":"Evaluating the risk profile of quetiapine in treating delirium in the intensive care adult population: a retrospective review","volume":"47","author":"Mangan KC","year":"2018","unstructured":"Mangan KC, McKinzie BP, Deloney LP, Leon SM, Eriksson EA. Evaluating the risk profile of quetiapine in treating delirium in the intensive care adult population: a retrospective review. J Crit Care. 2018, 47:169-72. 10.1016\/j.jcrc.2018.07.005","journal-title":"J Crit Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70166-8","article-title":"Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial","volume":"1","author":"Page VJ","year":"2013","unstructured":"Page VJ, Ely EW, Gates S, et al.. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013, 1:515-23. 10.1016\/S2213-2600(13)70166-8","journal-title":"Lancet Respir Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2011.01.019","article-title":"Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium","volume":"71","author":"Grover S","year":"2011","unstructured":"Grover S, Kumar V, Chakrabarti S. Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res. 2011, 71:277-81. 10.1016\/j.jpsychores.2011.01.019","journal-title":"J Psychosom Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/110266-haloperidol-versus-atypical-antipsychotics-for-treating-delirium-in-intensive-care-unit-patients-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:42:18Z","timestamp":1707507738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/110266-haloperidol-versus-atypical-antipsychotics-for-treating-delirium-in-intensive-care-unit-patients-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.30641","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,24]]}}}